Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2735333 | 0.88 | ALDH1A1 (0.42) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL216662 | 0.87 | MAPT (0.44) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL215290 | 0.86 | MAPT (0.39) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL2735332 | 0.86 | KMT2A (0.45) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL214444 | 0.86 | KMT2A (0.41) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL216400 | 0.84 | LMNA (0.46) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL2735276 | 0.84 | KMT2A (0.53) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL2735414 | 0.84 | KMT2A (0.53) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL215480 | 0.83 | MAPT (0.44) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL215041 | 0.83 | KMT2A (0.43) | ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088767-B2 | JAK-2 modulators and methods of use | EXELIXIS, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100136136-A1 | JAK-2 Modulators and Methods of Use | EXELIXIS, INC. (US) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136136-A1 | JAK-2 Modulators and Methods of Use | JAK2, JAK1, JAK3 | ALDH1A1 4295/4885MAPT 2138/4885KMT2A 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.